Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-08 Purchase |
2021-12-09 4:18 pm |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
10,000 | $9.3885 | $93,885 | 10,000 (Direct) |
View |
| 2021-05-05 Sale |
2021-05-07 4:21 pm |
GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer |
5,556 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-02 09:01 am |
N/A 2035-03-31 |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
36,979 | $0.98 | 36,979 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 8:15 pm |
N/A 2034-06-13 |
PLIANT THERAPEUTICS INC. | PLRX | Cline Darren S Director |
26,764 | $0 | 26,764 (Direct) |
View |
| 2024-03-26 Option Award |
2024-03-28 4:33 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
35,219 | $0 | 251,405 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 6:41 pm |
N/A 2033-06-15 |
IMPEL PHARMACEUTICALS INC | IMPL | Cline Darren S Director |
13,222 | $0 | 13,222 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-08 5:09 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | Cline Darren S Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 4:58 pm |
N/A 2033-04-11 |
IMPEL PHARMACEUTICALS INC | IMPL | Cline Darren S Director |
20,013 | $0 | 20,013 (Direct) |
View |
Ownership |
2023-04-13 6:10 pm |
N/A N/A |
IMPEL PHARMACEUTICALS INC | IMPL | Cline Darren S Director |
0 | $0 | 0 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:41 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
139,355 | $0 | 216,186 (Direct) |
View |
| 2023-03-06 Option Award |
2023-03-08 4:36 pm |
N/A 2033-03-06 |
PLIANT THERAPEUTICS INC. | PLRX | Cline Darren S Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
66,831 | $0 | 76,831 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
42,191 | $0 | 42,191 (Direct) |
View |
Ownership |
2021-10-07 9:10 pm |
N/A 2031-08-18 |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
0 | $0 | 15,725 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 9:05 pm |
N/A N/A |
GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer |
121,920 | $0 | 121,920 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 6:53 pm |
N/A N/A |
GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer |
121,920 | $0 | 121,920 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:15 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Cline Darren S Director |
35,468 | $0 | 0 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 8:00 pm |
N/A N/A |
GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer |
283,500 | $0 | 283,500 (Direct) |
View |
| 2020-05-28 Exercise |
2020-05-29 8:00 pm |
2020-05-28 2020-05-28 |
GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer |
7,356 | $0 | 5,556 (Direct) |
View |
| 2020-05-28 Tax Withholding |
2020-05-29 8:00 pm |
N/A N/A |
GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer |
1,800 | $10.54 | 5,556 (Direct) |
View |
| 2020-05-28 Exercise |
2020-05-29 8:00 pm |
N/A N/A |
GW PHARMACEUTICALS PLC | GWPH | Cline Darren S U.S. Chief Commercial Officer |
7,356 | $0.0012 | 5,556 (Direct) |
View |